Ani pharmaceuticals provides update on closing of acquisition of alimera sciences

Princeton, n.j., sept. 10, 2024 (globe newswire) -- ani pharmaceuticals, inc. (“ani” or “the company”) (nasdaq: anip) today provided an update on the status of the completion of its previously announced acquisition of alimera sciences, inc. (“alimera”) (nasdaq: alim).
ANIP Ratings Summary
ANIP Quant Ranking